USFDA gives approval to Aleor for Lidocaine & Prilocaine cream

Lidocaine and prilocaine cream is indicated as a topical anaesthetic

Picture: Pixabay

Last Updated on April 13, 2022 by The Health Master

Alembic Pharmaceuticals Limited‘s wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for lidocaine and prilocaine cream USP, 2.5%/2.5%.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Emla cream, 2.5%/2.5%, of Teva Branded Pharmaceutical Products R&D, Inc.

Lidocaine 2.5% and prilocaine 2.5% cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anaesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery.

And as pre-treatment for infiltration anaesthesia. Lidocaine 2.5% and prilocaine 2.5% cream is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effects observed in animal studies.

Lidocaine and prilocaine cream USP, 2.5%/2.5% has an estimated market size of US$ 29 million for twelve months ending December 2021 according to IQVIA. Alembic has received a cumulative total of 163 ANDA approvals (140 final approvals and 23 tentative approvals) from USFDA.

USFDA gives nod to Indoco Remedies for Lacosamide injection

USFDA gives tentative approval to Alembic for generic Pradaxa capsules

USFDA approves Cell Therapy for earlier lymphoma

USFDA approves Ozempic 2 mg to treat Type-II Diabetes

USFDA gives nod to Lupin for Sildenafil for oral suspension

USFDA gives approval to Glenmark Pharma for Lacosamide Tablets

Moderna recalls thousands of C-19 vaccine doses

USFDA gives Zero Observations to SMS Lifesciences

NPPA fixes ceiling price of these two vaccines

Online दवा बिक्री पर रोक लगाए सरकार, CAIT ने लगाई मंत्रियों से गुहार: Must read

After Cosmetics and Blood, now scientists detect microplastics in Lungs

CDSCO gives nod to Mylan to import and market Liposomal Amphotericin…

Indian Ophthalmic Manufacturers stress on importance of USFDA norms

42% of samples detected with prima facie violation of DPCO: Govt

USFDA gives nod to Indoco Remedies for Lacosamide injection

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner